Br J Pharmacol 179(4):659676 Hernandez AF, Green JB, Janmohamed S, DAgostino Sr RB, Granger CB, Jones NP, et al (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Some commenters stated that they look forward to working with CMS to identify and implement best practices for ASP data submission, and believed that clear guidance and streamlined reporting processes will help ensure that ASP data is complete and accurate, which supports a sustainable payment environment
For those with no known deficiencies or contraindications, vitamin B12 shots are often considered unnecessary and may not provide additional benefits
One such approach we might recommend is the use of semaglutide, a medication typically used for managing type 2 diabetes, which is effective in supporting weight loss
And while Dr